UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simultaneous analysis of acetylcarnitine, proline, hydroxyproline, citrulline, and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography–tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2019-02, Vol.165, p.101-111

2019

Volltextzugriff (PDF)

Recent progresses in exosome-based systems for targeted drug delivery to the brain

Journal of controlled release, 2022-08, Vol.348, p.723-744

2022

Volltextzugriff (PDF)

Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B

Antiviral research, 2018-10, Vol.158, p.185-198

2018

Volltextzugriff (PDF)

Chronic inflammatory mediators enhance prostate cancer development and progression

Biochemical pharmacology, 2015-03, Vol.94 (2), p.53-62

2015

Volltextzugriff (PDF)

Therapeutic Insights on Ferroptosis in Parkinson's disease

European journal of pharmacology, 2022-09, Vol.930, p.175133-175133, Article 175133

2022

Volltextzugriff (PDF)

Antioxidants for prostate cancer chemoprevention: Challenges and opportunities

Biochemical pharmacology, 2012-05, Vol.83 (10), p.1319-1330

2012

Volltextzugriff (PDF)

Cyclic nucleotide phosphodiesterase inhibition as a potential therapeutic target in renal ischemia reperfusion injury

Life sciences (1973), 2021-10, Vol.282, p.119843-119843, Article 119843

2021

Volltextzugriff (PDF)

Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases

Life sciences (1973), 2021-02, Vol.267, p.118975-118975, Article 118975

2021

Volltextzugriff (PDF)

Arginine as a protein stabilizer and destabilizer in liquid formulations

International journal of pharmaceutics, 2016-11, Vol.513 (1-2), p.26-37

2016

Volltextzugriff (PDF)

TRAIL therapy and prospective developments for cancer treatment

Journal of controlled release, 2020-10, Vol.326, p.335-349

2020

Volltextzugriff (PDF)

Retinoic acid signaling pathways in development and diseases

Bioorganic & medicinal chemistry, 2014-01, Vol.22 (2), p.673-683

2014

Volltextzugriff (PDF)

Helminth-based therapies for rheumatoid arthritis: A systematic review and meta-analysis

International immunopharmacology, 2019-01, Vol.66, p.366-372

2019

Volltextzugriff (PDF)

Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents

Bioorganic & medicinal chemistry, 2015-10, Vol.23 (19), p.6454-6466

2015

Volltextzugriff (PDF)

Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease

European journal of medicinal chemistry, 2017-09, Vol.137, p.575-597

2017

Volltextzugriff (PDF)

2-Thienyl-4-furyl-6-aryl pyridine derivatives: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study

Bioorganic & medicinal chemistry, 2010, Vol.18 (1), p.377-386

2010

Volltextzugriff (PDF)

Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor

European journal of medicinal chemistry, 2017-02, Vol.127, p.318-333

2017

Volltextzugriff (PDF)

Development of sorafenib loaded nanoparticles to improve oral bioavailability using a quality by design approach

International journal of pharmaceutics, 2019-07, Vol.566, p.229-238

2019

Volltextzugriff (PDF)

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity

Biomedicine & pharmacotherapy, 2024-08, Vol.177, p.117077, Article 117077

2024

Volltextzugriff (PDF)

Galangin as an inflammatory response modulator: An updated overview and therapeutic potential

Chemico-biological interactions, 2023-06, Vol.378, p.110482-110482, Article 110482

2023

Volltextzugriff (PDF)

Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity

European journal of medicinal chemistry, 2017-06, Vol.133, p.69-84

2017

Volltextzugriff (PDF)

Synthesis of novel quinolinomatrine derivatives and their insecticidal/acaricidal activities

Bioorganic & medicinal chemistry letters, 2018-06, Vol.28 (10), p.1753-1757

2018

Volltextzugriff (PDF)

Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy

Journal of controlled release, 2018-07, Vol.281, p.84-96

2018

Volltextzugriff (PDF)

Phase transforming in situ gels for sustained and controlled transmucosal drug delivery via the intravaginal route

International journal of pharmaceutics, 2024-04, Vol.655, p.124054-124054, Article 124054

2024

Volltextzugriff (PDF)

Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor

European journal of medicinal chemistry, 2015-01, Vol.90, p.302-314

2015

Volltextzugriff (PDF)

Novel 2-aryl-4-(4′-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors

European journal of medicinal chemistry, 2017-01, Vol.125, p.14-28

2017

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(81)
Science & Technology
(81)
Humans
(50)
Chemistry, Medicinal
(35)
Animals
(30)
Chemistry
(28)
Physical Sciences
(28)
Cell Line, Tumor
(26)
Antineoplastic Agents - Pharmacology
(24)
Pyridines - Pharmacology
(22)
Structure-Activity Relationship
(21)
Antineoplastic Agents - Chemical Synthesis
(20)
Chemistry, Organic
(20)
Pyridines - Chemical Synthesis
(19)
Antineoplastic Agents - Chemistry
(18)
Cytotoxicity
(18)
Pyridines - Chemistry
(17)
Biochemistry & Molecular Biology
(16)
Biological And Medical Sciences
(15)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Simultaneous analysis of acetylcarnitine, proline, hydroxyproline, citrulline, and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography–tandem mass spectrometry

Recent progresses in exosome-based systems for targeted drug delivery to the brain

Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B

Chronic inflammatory mediators enhance prostate cancer development and progression

Therapeutic Insights on Ferroptosis in Parkinson's disease

Antioxidants for prostate cancer chemoprevention: Challenges and opportunities

Cyclic nucleotide phosphodiesterase inhibition as a potential therapeutic target in renal ischemia reperfusion injury

Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases

Arginine as a protein stabilizer and destabilizer in liquid formulations

TRAIL therapy and prospective developments for cancer treatment

Retinoic acid signaling pathways in development and diseases

Helminth-based therapies for rheumatoid arthritis: A systematic review and meta-analysis

Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents

Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease

2-Thienyl-4-furyl-6-aryl pyridine derivatives: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study

Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor

Development of sorafenib loaded nanoparticles to improve oral bioavailability using a quality by design approach

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity

Galangin as an inflammatory response modulator: An updated overview and therapeutic potential

Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity

Synthesis of novel quinolinomatrine derivatives and their insecticidal/acaricidal activities

Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy

Phase transforming in situ gels for sustained and controlled transmucosal drug delivery via the intravaginal route

Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor

Novel 2-aryl-4-(4′-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors

Aktive Filter

Suchergebnisse filtern